Bringing Synthetic Biology to the market: An Australia and Singapore perspective

BRINGING SYNTHETIC BIOLOGY TO THE MARKET: AN AUSTRALIA AND SINGAPORE PERSPECTIVE

‍

‍

We kick start August with our first SBA-SINERGY joint event - a Webinar on bringing synthetic biology technology from lab to the market with a focus on the landscapes in Australia andSingapore. The Webinar was well attended with >120 attendees from Australia and Singapore. We brought together 9 experts.

The first session moderated by Anna Tao from CSIRO consists of Start-up Founders panel members Alvin NG (EscoAster, Ling Ka Yi (Shiok Meats), Anna El Tahchy (Nourish Ingredients), and Gustavo De Cerqueira (Cluster Biotechnology), where opportunities and challenges for synthetic biology start-ups were discussed.

One common theme that was raised is the challenges of securing skilled labour in the synthetic biology areas. Good news for Synthetic Biology Graduates and ECRs, you are much needed!! We also heard about different models of scaling infrastructures(building in-house capacity or outsourcing).

Next, we have David Toh from Ntuitive moderating a session with an Investor panel consist of Alice Chen (Acceleration Life Science Partners), Chong Yoke Sin (iGlobe Partners) and Phil Morle (Main Sequence Ventures).

It was exciting to hear that the investors find that Synthetic Biology is one of the most promising technological growth areas worth investing in the next ten years! There were further insightful discussions on working with universities and their TTOs and some valuable advices for prospective founders.

If you have missed this inspiring and insightful webinar, you can watch them on:

Founders panel: https://www.youtube.com/watch?v=fwY-uhLqvBI
Investors panel: https://www.youtube.com/watch?v=RvsUgeXVPu4

‍